| Panacea Biotec Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531349 |
NSE Symbol : PANACEABIO |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE922B01023 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 47.62 |
Market Cap(₹Cr) : 2,111.01 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 90.81 | 112.25 | 67.90 | 108.43 | 76.64 | 56.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 90.81 | 112.25 | 67.90 | 108.43 | 76.64 | 56.88 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.61 | 4.95 | 6.09 | 3.32 | 3.41 | 3.80 |
| Total Income | 94.42 | 117.20 | 73.99 | 111.75 | 80.05 | 60.68 |
| Total Expenditure | 104.51 | 115.27 | 86.47 | 93.04 | 69.90 | 67.37 |
| PBIDT | -10.09 | 1.93 | -12.48 | 18.71 | 10.15 | -6.69 |
| Interest | 5.93 | 6.00 | 4.64 | 3.85 | 3.76 | 3.21 |
| PBDT | -16.02 | -4.07 | -17.12 | 14.86 | 6.39 | -9.90 |
| Depreciation | 4.91 | 4.77 | 4.91 | 5.21 | 5.09 | 5.08 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.29 | -2.14 | -9.64 | 0.00 | 0.01 | -1.20 |
| Reported Profit After Tax | -15.64 | -6.70 | -12.39 | 9.65 | 1.29 | -13.78 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -15.64 | -6.70 | -12.39 | 9.65 | 1.29 | -13.78 |
| EPS (Unit Curr.) | -2.55 | -1.09 | -2.02 | 1.58 | 0.21 | -2.25 |
| EPS (Adj) (Unit Curr.) | -2.55 | -1.09 | -2.02 | 1.58 | 0.21 | -2.25 |
| Calculated EPS (Unit Curr.) | -2.55 | -1.09 | -2.02 | 1.57 | 0.21 | -2.25 |
| Calculated EPS (Adj) (Unit Curr.) | -2.55 | -1.09 | -2.02 | 1.57 | 0.21 | -2.25 |
| Calculated EPS (Ann.) (Unit Curr.) | -10.21 | -4.37 | -8.08 | 6.30 | 0.84 | -8.99 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -10.21 | -4.37 | -8.08 | 6.30 | 0.84 | -8.99 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -11.11 | 1.72 | -18.38 | 17.26 | 13.24 | -11.76 |
| PBDTM(%) | -17.64 | -3.63 | -25.21 | 13.70 | 8.34 | -17.41 |
| PATM(%) | -17.22 | -5.97 | -18.25 | 8.90 | 1.68 | -24.23 |